220 related articles for article (PubMed ID: 33908709)
1. Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.
Daix M; Angeles MA; Migliorelli F; Kakkos A; Martinez Gomez C; Delbecque K; Mery E; Tock S; Gabiache E; Decuypere M; Goffin F; Martinez A; Ferron G; Kridelka F
J Gynecol Oncol; 2021 Jul; 32(4):e48. PubMed ID: 33908709
[TBL] [Abstract][Full Text] [Related]
2. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
3. Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer.
Lavaud P; Fedida B; Canlorbe G; Bendifallah S; Darai E; Thomassin-Naggara I
Diagn Interv Imaging; 2018 Jun; 99(6):387-396. PubMed ID: 29472031
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
[TBL] [Abstract][Full Text] [Related]
5. Preoperative assessment in endometrial cancer. Is triage for lymphadenectomy possible?
Tsikouras P; Koukouli Z; Bothou A; Manav B; Iatrakis G; Zervoudis S; Galazios G; Tobias Teichmann A
J BUON; 2017; 22(1):34-43. PubMed ID: 28365933
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract][Full Text] [Related]
7. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging.
Gultekin M; Guler OC; Yuce Sari S; Akkus Yildirim B; Onal C; Celik H; Yuce K; Ayhan A; Arik Z; Kose F; Altundag O; Zoto Mustafayev T; Atalar B; Bolukbasi Y; Yildiz F
J Obstet Gynaecol; 2021 Apr; 41(3):414-420. PubMed ID: 32347768
[TBL] [Abstract][Full Text] [Related]
9. Nodal Assessment in Endometrial Atypical Hyperplasia.
Capozzi VA; Sozzi G; Butera D; Chiantera V; Ghi T; Berretta R
Gynecol Obstet Invest; 2022; 87(3-4):226-231. PubMed ID: 35793641
[TBL] [Abstract][Full Text] [Related]
10. Are preoperative histology and MRI useful for classification of endometrial cancer risk?
Body N; Lavoué V; De Kerdaniel O; Foucher F; Henno S; Cauchois A; Laviolle B; Leblanc M; Levêque J
BMC Cancer; 2016 Jul; 16():498. PubMed ID: 27430321
[TBL] [Abstract][Full Text] [Related]
11. Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR).
Angeles MA; Migliorelli F; Vidal-Sicart S; Saco A; Ordi J; Ros C; Fusté P; Munmany M; Escura S; Carreras N; Sánchez-Izquierdo N; Pahisa J; Torné A; Paredes P; Del Pino M
J Gynecol Oncol; 2021 Jul; 32(4):e52. PubMed ID: 33908710
[TBL] [Abstract][Full Text] [Related]
12. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
Ballester M; Koskas M; Coutant C; Chéreau E; Seror J; Rouzier R; Daraï E
BMC Cancer; 2010 Aug; 10():465. PubMed ID: 20804553
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.
Korkmaz V; Meydanli MM; Yalçın I; Sarı ME; Sahin H; Kocaman E; Haberal A; Dursun P; Güngör T; Ayhan A
J Gynecol Oncol; 2017 Nov; 28(6):e78. PubMed ID: 29027396
[TBL] [Abstract][Full Text] [Related]
14. Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer.
Naoura I; Canlorbe G; Bendifallah S; Ballester M; Daraï E
Gynecol Oncol; 2015 Jan; 136(1):60-4. PubMed ID: 25449312
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified Under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results From a Single Institution.
Kumar UP; Yathiraj PH; Sharan KT; Kamath A; Singh A; Reddy SA; Alurkar P; Fernandes DJ; Mamidipudi VS
Int J Gynecol Cancer; 2018 Jun; 28(5):854-860. PubMed ID: 29683879
[TBL] [Abstract][Full Text] [Related]
16. Combined deep-learning MRI-based radiomic models for preoperative risk classification of endometrial endometrioid adenocarcinoma.
Yang J; Cao Y; Zhou F; Li C; Lv J; Li P
Front Oncol; 2023; 13():1231497. PubMed ID: 37909025
[TBL] [Abstract][Full Text] [Related]
17. Importance of pre-operative ultrasound examination and pathological tumour evaluation in the management of women with endometrial cancer.
Sobočan M; Ogrizek AM; Ledinek T; Takač I; Knez J
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():121-126. PubMed ID: 33383411
[TBL] [Abstract][Full Text] [Related]
18. Utility of the relative apparent diffusion coefficient for preoperative assessment of low risk endometrial carcinoma.
Shen Y; Lv F; Xiao Z; Bi Q
Clin Imaging; 2019; 56():28-32. PubMed ID: 30851496
[TBL] [Abstract][Full Text] [Related]
19. [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer].
Ballester M; Bendifallah S; Daraï E
Bull Cancer; 2017 Dec; 104(12):1032-1038. PubMed ID: 29173977
[TBL] [Abstract][Full Text] [Related]
20. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
